Andreas Ole Halvorsen Net Worth & Insider Trades

Andreas Ole Halvorsen Zentalis Pharmaceuticals, Inc

As of December 3, 2020

What is Andreas Ole Halvorsen's Net Worth?

The current estimated net worth of Zentalis Pharmaceuticals, Inc's Andreas Ole Halvorsen is estimated to be about $13.6B . Andreas Ole Halvorsen owns about 3,943,284 units of Zentalis Pharmaceuticals, Inc common stock. In the last 9 months at Zentalis Pharmaceuticals, Inc, Andreas Ole Halvorsen has sold an estimated value of $25.25M worth.

What is Andreas Ole Halvorsen's Past Insider Trading?

Andreas Ole Halvorsen's largest purchase order was 725,000 units , worth over $13.05M on April 8, 2020. Andreas Ole Halvorsen's largest sale order was 500,000 units , worth over $25.25M on December 3, 2020. In total, Andreas Ole Halvorsen has made about 2 transactions over 9 months of their time at Zentalis Pharmaceuticals, Inc. Andreas Ole Halvorsen usually trades in April and December, with the busiest year in 2020.

VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Illiquid Investments SubMaster LP, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities GP LLC, ANDREAS OLE HALVORSEN, David Ott, Sharon Rose Shabet

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Andreas Ole Halvorsen's' Mailing Address?

  • Mailing address is C/o Viking Global Investors Lp 280 Park Ave 35th New York NY 10017 NY

Zentalis Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Anthony Sun, M.D. 2020 $561,232 - $8,100,645 $5,986,469 $287,375 $108,678 $15,044,399
Anthony Sun, M.D. 2019 $455,091 - - $918,000 $204,971 - $1,577,882
Kevin Bunker, Ph.D. 2020 $428,771 - $2,580,864 $2,993,235 $179,550 $91,174 $6,273,594
Kevin Bunker, Ph.D. 2019 $360,024 - - $275,400 $144,010 - $779,434
Alexis M. Pinto 2020 $136,923 - - $6,234,468 $152,000 $10,511 $6,533,902
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1725160/000172516021000099/proxystatement-2021.htm

What are Zentalis Pharmaceuticals, Inc's Past Insider Trades?

Zentalis Pharmaceuticals, Inc's most recent insider trade came on September 16, 2022 by Cam Gallagher who sold 22,500 units worth $560.25K . In the last 2 years, insiders at Zentalis Pharmaceuticals, Inc have sold an estimated value of $105.11M and bought an estimated value of $15.77M worth of shares. Insider trading is most common in February, with the busiest year in 2021. The most active traders at the company are Kevin D Bunker, Chief Operating Officer,  Cam Gallagher, President,  and Anthony ySun, President & CEO .

Zentalis Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1